title: Increased Virus Replication and Cytotoxicity of Non-pathogenic Simian Human Immuno Deficiency Viruses-NM-3rN After Serial Passage in a Monkey-Derived Cell Line.
abstract: BACKGROUND
  Infection and disease induction of variants of HIV type 1 (HIV-1) in vivo, especially their persistence, replication and rate of disease progression, have been found to depend on phenotypic characteristics. However, the mechanism (s) underlying these diverse phenotypic characteristics remain poorly understood.
  
  
  OBJECTIVE
  It was aimed at determining whether a SHIV that had been adapted to a monkey-derived cell line could be used to explain the mechanism that underlies adaptive evolution of a virus to its host cell environment.
  
  
  METHODS
  Standard procedures in virology such as cell culturing, FACS analysis and ELISA were employed to measure virus replication and growth kinetics, cell viability, reverse transcriptase (RT) activity assay and CD4 cells down-regulation.
  
  
  RESULTS
  After about 20 passages, LT efficiently adapted to the monkey-derived cell line and replicated much better than the parent virus. LT accumulated a number of mutations in its entire genome with a majority of them being monkey cell-specific.
  
  
  CONCLUSIONS
  Thus we think we have obtained a virus that may enable studies to determine which of these mutations are specifically related to in vitro viral replication and which are specifically related to cytotoxicity so as to explain the mechanism associated with viral cytotoxicity and host cell specificity.
authors: Departments of Clinical Microbiology, School of Medical Sciences, College Health Science, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
authors: Tb
authors: T
authors: Kwofie
authors: T
authors: T
authors: Miura
keywords: Cell culture; Evolution; HIV/SIV; Monkey; Replication
references: AIDS. 1996 Oct;10(12):1331-7
references: 8902061
references: Science. 1998 Jun 19;280(5371):1875-80
references: 9632379
references: J Virol. 1993 Jan;67(1):577-83
references: 8416384
references: AIDS. 1989;3 Suppl 1:S5-12
references: 2514754
references: Clin Immunol. 1999 Jun;91(3):321-9
references: 10370378
references: Virology. 1999 Dec 20;265(2):252-63
references: 10600597
references: Lancet. 1986 Sep 20;2(8508):660-2
references: 2429124
references: AIDS Res Hum Retroviruses. 1997 Jul 20;13(11):913-22
references: 9223407
references: J Virol. 1987 May;61(5):1602-8
references: 3033285
references: J Virol. 1993 Mar;67(3):1727-33
references: 8437241
references: J Virol. 2001 Apr;75(8):3753-65
references: 11264364
references: Cell. 1995 Jul 28;82(2):177-82
references: 7628008
references: Virology. 1990 Jan;174(1):103-16
references: 1688473
references: Virology. 1987 May;158(1):44-51
references: 3107214
references: Lancet. 1997 Nov 29;350(9091):1617-21
references: 9393353
references: Cell. 1991 May 17;65(4):651-62
references: 2032289
references: J Virol. 1996 Oct;70(10):6922-8
references: 8794335
references: J Acquir Immune Defic Syndr (1988). 1992;5(7):639-46
references: 1613662
references: J Gen Virol. 1995 Sep;76 ( Pt 9):2181-91
references: 7561755
references: AIDS Res Hum Retroviruses. 1994 Aug;10(8):1021-9
references: 7811533
references: J Gen Virol. 1997 May;78 ( Pt 5):985-9
references: 9152414
references: Nature. 2001 Apr 19;410(6831):1002-7
references: 11309631
references: Science. 1995 Mar 24;267(5205):1820-5
references: 7892606